TERT and glioma: Myriad Genetics (Salt Lake City, United States) features the RUO NGS panel, PreciseTM Tumor, for solid tumor characterization covering 523 genes by DNA sequencing and with most glioma-related SNPs, but missing p-TERT DNA sequence alterations (PreciseTM Tumor | Molecular Profile Testing | Myriad Genetics, 2023).